TP53 and neoplasm: Additional features that were associated with poor prognosis in the large case series studied by panel and exome sequencing included grade 3 ILC, an ER-negative phenotype, mutations in TP53 or ERBB2, and a high tumour substitution mutation burden (>5 mutations/Mb).